WallStreetZenWallStreetZen

NASDAQ: DCTH
Delcath Systems Inc Stock

$8.03+0.46 (+6.08%)
Updated May 20, 2024
DCTH Price
$8.03
Fair Value Price
-$4.33
Market Cap
$223.12M
52 Week Low
$2.25
52 Week High
$8.18
P/E
-3.21x
P/B
15.26x
P/S
25.77x
PEG
N/A
Dividend Yield
N/A
Revenue
$4.61M
Earnings
-$49.79M
Gross Margin
70.5%
Operating Margin
-1,060.1%
Profit Margin
-1,080.7%
Debt to Equity
1.47
Operating Cash Flow
-$37M
Beta
1.18
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

DCTH Overview

Delcath Systems, Inc. is a specialty pharmaceutical and medical device company focused on the treatment of primary and metastatic liver cancers. The firm's lead candidates, Melphalan Hydrochloride for Injection and the Delcath Hepatic Delivery System are designed to administer high-dose chemotherapy to the liver while controlling side effects. The company was founded in 1988 and is based in Queensbury, NY.

Zen Score

Industry Average (26)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how DCTH scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

DCTH ($8.03) is overvalued by 285.43% relative to our estimate of its Fair Value price of -$4.33 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
DCTH ($8.03) is not significantly undervalued (285.43%) relative to our estimate of its Fair Value price of -$4.33 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
DCTH is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more DCTH due diligence checks available for Premium users.

Be the first to know about important DCTH news, forecast changes, insider trades & much more!

DCTH News

Valuation

DCTH fair value

Fair Value of DCTH stock based on Discounted Cash Flow (DCF)
Price
$8.03
Fair Value
-$4.33
Undervalued by
285.43%
DCTH ($8.03) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
DCTH ($8.03) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
DCTH is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

DCTH price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-3.21x
Industry
30.55x
Market
31.12x

DCTH price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
15.26x
Industry
3.98x
DCTH is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation

DCTH's financial health

Profit margin

Revenue
$3.1M
Net Income
-$11.1M
Profit Margin
-354%
DCTH's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
DCTH's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$36.1M
Liabilities
$21.5M
Debt to equity
1.47
DCTH's short-term assets ($33.65M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
DCTH's short-term assets ($33.65M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
DCTH's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
DCTH's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$9.6M
Investing
$4.7M
Financing
$4.0M
DCTH's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

DCTH vs Medical Device Stocks

TickerMarket Cap1d %P/EP/B
DCTH$223.12M+6.08%-3.21x15.26x
BFLY$219.14M+0.97%-1.79x1.07x
NPCE$229.57M-2.33%-6.76x16.01x
RCEL$210.78M-1.21%-4.64x6.47x
MASS$236.22M0.00%-6.40x1.51x

Delcath Systems Stock FAQ

What is Delcath Systems's quote symbol?

(NASDAQ: DCTH) Delcath Systems trades on the NASDAQ under the ticker symbol DCTH. Delcath Systems stock quotes can also be displayed as NASDAQ: DCTH.

If you're new to stock investing, here's how to buy Delcath Systems stock.

What is the 52 week high and low for Delcath Systems (NASDAQ: DCTH)?

(NASDAQ: DCTH) Delcath Systems's 52-week high was $8.18, and its 52-week low was $2.25. It is currently -1.83% from its 52-week high and 256.89% from its 52-week low.

How much is Delcath Systems stock worth today?

(NASDAQ: DCTH) Delcath Systems currently has 27,785,803 outstanding shares. With Delcath Systems stock trading at $8.03 per share, the total value of Delcath Systems stock (market capitalization) is $223.12M.

Delcath Systems stock was originally listed at a price of $945.00 in May 3, 2018. If you had invested in Delcath Systems stock at $945.00, your return over the last 6 years would have been -99.15%, for an annualized return of -54.83% (not including any dividends or dividend reinvestments).

How much is Delcath Systems's stock price per share?

(NASDAQ: DCTH) Delcath Systems stock price per share is $8.03 today (as of May 20, 2024).

What is Delcath Systems's Market Cap?

(NASDAQ: DCTH) Delcath Systems's market cap is $223.12M, as of May 22, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Delcath Systems's market cap is calculated by multiplying DCTH's current stock price of $8.03 by DCTH's total outstanding shares of 27,785,803.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.